Staging System for HPV-Related Oropharynx Cancer Paves Way for Change

Robert I. Haddad, MD
Published: Monday, May 13, 2019
UVARobert I. Haddad, MD
Robert I. Haddad, MD
Division of Head and Neck Oncology  Dana-Farber Cancer Institute
Professor of medicine
Harvard Medical School
Boston, Massachusetts

Strategic Partnership
A new staging system for head and neck cancers recognizes that patients with oropharyngeal (OP) malignancies associated with the human papillomavirus (HPV) often have an excellent prognosis, but efforts to deintensify therapy for this population based on a fresh understanding of favorable risk factors may be premature.
... to read the full story
To Read the Full Story

View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Medical Crossfire®: How Can We Optimize Outcomes in Head and Neck Cancers with Immunotherapeutic Strategies?Oct 31, 20191.5
Publication Bottom Border
Border Publication